Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2025-12-28 @ 12:46 PM
Study NCT ID:
NCT03425461
Status:
TERMINATED
Last Update Posted:
2021-04-02
First Post:
2018-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
Sponsor:
Jonsson Comprehensive Cancer Center